Establishment Labs Holdings Ord
(ESTA)
|
11.7 |
$28M |
|
510k |
54.38 |
Kura Oncology
(KURA)
|
7.2 |
$17M |
|
928k |
18.33 |
Chinook Therapeutics
|
6.9 |
$16M |
|
938k |
17.49 |
Inari Medical Ord
(NARI)
|
6.4 |
$15M |
|
222k |
67.99 |
Lantheus Holdings Inc Common Stock Usd 0.01
(LNTH)
|
5.8 |
$14M |
|
210k |
66.03 |
Ascendis Pharma A/s Sponsored Adr
(ASND)
|
4.9 |
$12M |
|
125k |
92.96 |
Karuna Therapeutics Ord
|
4.8 |
$11M |
|
90k |
126.51 |
Travere Therapeutics Note 2.500% 9/1 (Principal)
|
4.6 |
$11M |
|
11M |
0.99 |
Eli Lilly & Co. Call Option
(LLY)
|
4.1 |
$9.7M |
|
30k |
324.23 |
Novavax Com New Put Option
(NVAX)
|
3.8 |
$9.0M |
|
175k |
51.43 |
Nanostring Technologies Note 2.625% 3/0 (Principal)
|
3.4 |
$8.0M |
|
10M |
0.80 |
Madrigal Pharmaceuticals
(MDGL)
|
3.0 |
$7.2M |
|
100k |
71.58 |
Horizon Therapeutics Pub L SHS
|
2.5 |
$6.0M |
|
75k |
79.76 |
Astrazeneca Sponsored Adr
(AZN)
|
2.4 |
$5.6M |
|
85k |
66.07 |
Celldex Therapeutics Com New
(CLDX)
|
2.1 |
$5.0M |
|
185k |
26.95 |
Morphic Hldg
(MORF)
|
2.0 |
$4.7M |
|
216k |
21.70 |
Bellus Health Com New
|
1.9 |
$4.6M |
|
493k |
9.24 |
Repare Therapeutics Ord
(RPTX)
|
1.9 |
$4.5M |
|
321k |
13.99 |
Crispr Therapeutics Namen Akt Call Option
(CRSP)
|
1.8 |
$4.3M |
|
70k |
60.77 |
Bridgebio Pharma Note 2.250% 2/0 (Principal)
|
1.8 |
$4.2M |
|
10M |
0.42 |
Bridgebio Pharma Note 2.500% 3/1 (Principal)
|
1.8 |
$4.2M |
|
7.5M |
0.55 |
Cymabay Therapeutics
|
1.7 |
$4.0M |
|
1.4M |
2.95 |
Rocket Pharmaceuticals
(RCKT)
|
1.5 |
$3.4M |
|
251k |
13.76 |
Arya Sciences Acquisitn Corp Class A Ord Shs
|
1.4 |
$3.4M |
|
353k |
9.72 |
Legend Biotech Corp Sponsored Ads Call Option
(LEGN)
|
1.2 |
$2.8M |
|
50k |
55.00 |
Moderna Call Option
(MRNA)
|
0.9 |
$2.1M |
|
15k |
142.87 |
Zentalis Pharmaceuticals
(ZNTL)
|
0.8 |
$2.0M |
|
70k |
28.10 |
Context Therapeutics
(CNTX)
|
0.8 |
$1.9M |
|
884k |
2.12 |
Vincerx Pharma Com New
(VINC)
|
0.8 |
$1.8M |
|
1.4M |
1.32 |
Fate Therapeutics Call Option
(FATE)
|
0.7 |
$1.7M |
|
68k |
24.79 |
Iovance Biotherapeutics Call Option
(IOVA)
|
0.7 |
$1.7M |
|
150k |
11.04 |
Aclaris Therapeutics
(ACRS)
|
0.6 |
$1.4M |
|
100k |
13.96 |
Arcellx Common Stock
(ACLX)
|
0.6 |
$1.4M |
|
75k |
18.08 |
Nautilus Biotechnology
(NAUT)
|
0.5 |
$1.3M |
|
467k |
2.69 |
Cogent Biosciences
(COGT)
|
0.5 |
$1.1M |
|
125k |
9.02 |
Terns Pharmaceuticals
(TERN)
|
0.4 |
$995k |
|
401k |
2.48 |
Lianbio Sponsored Ads
(LIANY)
|
0.4 |
$972k |
|
450k |
2.16 |
Silverback Therapeutics
(SPRY)
|
0.3 |
$721k |
|
170k |
4.24 |
Celularity Com Cl A Put Option
|
0.3 |
$624k |
|
184k |
3.40 |
Cytokinetics Com New
(CYTK)
|
0.2 |
$589k |
|
15k |
39.27 |
Science 37 Holdings
|
0.2 |
$562k |
|
280k |
2.01 |
Renovacor
|
0.2 |
$405k |
|
200k |
2.03 |
Enochian Biosciences Put Option
(RENB)
|
0.2 |
$386k |
|
200k |
1.93 |
Immatics *w Exp 07/01/202
(IMTXW)
|
0.2 |
$382k |
|
187k |
2.04 |
Curis Com New
|
0.1 |
$335k |
|
340k |
0.98 |
Miragen Therapeutics
(VRDN)
|
0.1 |
$239k |
|
21k |
11.57 |
Point Biopharma Global
|
0.1 |
$174k |
|
26k |
6.80 |
Medicus Sciences Acquisition *w Exp 02/12/202
|
0.0 |
$8.0k |
|
33k |
0.24 |
Renovacor *w Exp 99/99/999
|
0.0 |
$5.0k |
|
75k |
0.07 |